Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Clinical Research

Vol 9 No 2 (2024): December

Association between Relative Risk Factor (RR) and ABO Blood Groups with Clinical Parameters in Patients with SARS-Cov-2
Hubungan antara Faktor Risiko Relatif (RR) dan Golongan Darah ABO dengan Parameter Klinis pada Pasien SARS-Cov-2



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.9156
Published
June 23, 2024

Abstract

This study investigates the correlation between ABO blood groups and SARS-CoV-2 infection among 1,303 participants from Babylon, comprising 397 infected individuals and 906 healthy controls. It explores three primary axes: genetic inheritance of ABO blood groups in 200 families, distribution of these blood groups in the context of SARS-CoV-2 infection, and the relationship of these blood groups with various physiological indicators in infected, recovered, and healthy subjects. The findings reveal that the AB blood group is disproportionately associated with a higher infection rate (RR = 1.808), whereas the O group shows a lesser susceptibility (RR = 0.901). Additionally, physiological changes such as decreased lymphocytes, MCH, and MCHC, alongside increased WBC, CRP, Ferritin, D-dimer, and LDH levels were noted in infected individuals. This study underscores the potential of ABO blood groups as a factor in COVID-19 infection risk, suggesting a direction for future research into tailored medical responses based on genetic predispositions.

Highlights:

  • Blood Group Impact: AB group had higher COVID-19 infection rates; O group had lower.
  • Physiological Indicators: Infected individuals showed significant changes in key blood parameters.
  • Medical Strategy: Findings suggest potential for personalized medical approaches based on ABO blood groups.

Keywords: SARS-Cov-2, ABO Blood Groups, Relative Risk Factor

References

  1. B. Tang, N. L. Bragazzi, Q. Li, S. Tang, Y. Xiao, and J. Wu, "An Updated Estimation of the Risk of Transmission of the Novel Coronavirus (2019-nCov)," Infectious Disease Modelling, vol. 5, pp. 248-255, 2020.
  2. B. Ganesh, T. Rajakumar, M. Malathi, N. Manikandan, J. Nagaraj, A. Santhakumar, A. Elangovan, and Y. S. Malik, "Epidemiology and Pathobiology of SARS-CoV-2 (COVID-19) in Comparison with SARS, MERS: An Updated Overview of Current Knowledge and Future Perspectives," Clinical Epidemiology and Global Health, vol. 10, pp. 100694, Apr. 2021.
  3. World Health Organization, "WHO Report on the Global Tobacco Epidemic, 2021: Addressing New and Emerging Products," World Health Organization, 2021.
  4. S. Samadizadeh, M. Masoudi, M. Rastegar, V. Salimi, M. B. Shahbaz, and A. Tahamtan, "COVID-19: Why Does Disease Severity Vary Among Individuals?," Respiratory Medicine, vol. 180, pp. 106-356, Apr. 2021.
  5. A. Ayatollahi, B. Aghcheli, A. Amini, H. Nikbakht, P. Ghassemzadehpirsala, E. Behboudi, A. Rajabi, and A. Tahamtan, "Association Between Blood Groups and COVID-19 Outcome in Iranian Patients," Future Virology, vol. 10.2217/fvl, pp. 2021-0090, Aug. 2021.
  6. J. M. Serpeloni, Q. A. L. Neto, L. C. Lucio, A. Ramao, J. C. de Oliveira, D. F. Gradia, D. Malheiros, A. Ferrasa, R. Marchi, D. L. Figueiredo, and W. A. Silva Jr., "Genome Interaction of the Virus and the Host Genes and Non-Coding RNAs in SARS-CoV-2 Infection," Immunobiology, vol. 226, no. 5, pp. 152-130, 2021.
  7. P. Soret, C. Le Dantec, E. Desvaux, N. Foulquier, B. Chassagnol, S. Hubert, C. Jamin, G. Barturen, G. Desachy, V. Devauchelle-Pensec, and C. Boudjeniba, "A New Molecular Classification to Drive Precision Treatment Strategies in Primary Sjögren’s Syndrome," Nature Communications, vol. 12, no. 1, pp. 3523, 2021.
  8. Y. Zhang, M. Xiao, S. Zhang, P. Xia, W. Cao, W. Jiang, H. Chen, X. Ding, H. Zhao, H. Zhang, and C. Wang, "Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19," New England Journal of Medicine, vol. 382, no. 17, p. e38, 2020.
  9. W. J. Guan, Z. Y. Ni, Y. Hu, W. H. Liang, C. Q. Ou, J. X. He, L. Liu, H. Shan, C. L. Lei, D. S. Hui, and B. Du, "Clinical Characteristics of Coronavirus Disease 2019 in China," New England Journal of Medicine, vol. 382, no. 18, pp. 1708-1720, 2020.
  10. H. Singh, "Building Effective Blended Learning Programs," in Challenges and Opportunities for the Global Implementation of E-Learning Frameworks, IGI Global, pp. 15-23, 2021.
  11. Al-Janobi, S. Al-Hamed, A. Aboukarima, and Y. Almajhadi, "Modeling of Draft and Energy Requirements of a Moldboard Plow Using Artificial Neural Networks Based on Two Novel Variables," Engenharia Agrícola, vol. 40, pp. 363-373, 2020.
  12. A. Zhao, C. Ni, R. Gao, Y. Wang, L. Yang, J. Wei, T. Lv, J. Liang, Q. Zhang, W. Xu, and Y. Xie, "Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Ductal Organoids," Protein & Cell, vol. 11, no. 10, pp. 771-775, 2020.
  13. Mendy, S. Apewokin, A. A. Wells, and A. L. Morrow, "Factors Associated with Hospitalization and Disease Severity in a Racially and Ethnically Diverse Population of COVID-19 Patients," MedRxiv, pp. 2020-06, 2020.
  14. M. A. K. Adhi and M. Golczak, "The Molecular Aspects of Absorption and Metabolism of Carotenoids and Retinoids in Vertebrates," Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1865, no. 11, pp. 158571, 2020.
  15. R. S. Mouhamad and M. Alabboud, "Plant Growth-Promoting Bacteria as a Natural Resource for Sustainable Rice Production Under the Soil Salinity, Wastewater, and Heavy Metal Stress," in Plant Stress Physiology, IntechOpen, London, UK, 2020.
  16. X. Li, L. Wang, S. Yan, F. Yang, L. Xiang, J. Zhu, B. Shen, and Z. Gong, "Clinical Characteristics of 25 Death Cases with COVID-19: A Retrospective Review of Medical Records in a Single Medical Center, Wuhan, China," International Journal of Infectious Diseases, vol. 94, pp. 128-132, 2020.
  17. S. Feng, C. Shen, N. Xia, W. Song, M. Fan, and B. J. Cowling, "Rational Use of Face Masks in the COVID-19 Pandemic," The Lancet Respiratory Medicine, vol. 8, no. 5, pp. 434-436, 2020.
  18. Khalil, R. Feghali, and M. Hassoun, "The Lebanese COVID-19 Cohort; A Challenge for the ABO Blood Group System," Frontiers in Medicine, vol. 7, pp. 58534, Nov. 2020.
  19. W. F. Zhang, Y. L. He, M. S. Zhang, Z. Yin, and Q. Chen, "Raman Scattering Study on Anatase TiO2 Nanocrystals," Journal of Physics D: Applied Physics, vol. 33, no. 8, p. 912, 2000.
  20. K. A. Overmyer, E. Shishkova, I. J. Miller, J. Balnis, M. N. Bernstein, T. M. Peters-Clarke, J. G. Meyer, Q. Quan, L. K. Muehlbauer, E. A. Trujillo, and Y. He, "Large-Scale Multi-Omic Analysis of COVID-19 Severity," Cell Systems, vol. 12, no. 1, pp. 23-40, 2021.
  21. H. Yao, Y. Song, Y. Chen, N. Wu, J. Xu, C. Sun, J. Zhang, T. Weng, Z. Zhang, Z. Wu, and L. Cheng, "Molecular Architecture of the SARS-CoV-2 Virus," Cell, vol. 183, no. 3, pp. 730-738, 2020.

Downloads

Download data is not yet available.